0001209191-20-064914.txt : 20201222
0001209191-20-064914.hdr.sgml : 20201222
20201222184929
ACCESSION NUMBER: 0001209191-20-064914
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201218
FILED AS OF DATE: 20201222
DATE AS OF CHANGE: 20201222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NORTHCOTT JOHN
CENTRAL INDEX KEY: 0001615000
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24006
FILM NUMBER: 201409348
MAIL ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH
STREET 2: C/O NEKTAR THERAPEUTICS
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS
CENTRAL INDEX KEY: 0000906709
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943134940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 4154825300
MAIL ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
FORMER COMPANY:
FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC
DATE OF NAME CHANGE: 19980723
FORMER COMPANY:
FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS
DATE OF NAME CHANGE: 19940303
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-18
0
0000906709
NEKTAR THERAPEUTICS
NKTR
0001615000
NORTHCOTT JOHN
C/O NEKTAR THERAPEUTICS
455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO
CA
94185
0
1
0
0
SVP & Chief Commercial Officer
Common Stock
2020-12-18
4
A
0
28550
0.00
A
228550
D
Stock Option
18.75
2020-12-18
4
A
0
51000
0.00
A
2028-12-17
Common Stock
51000
51000
D
This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. These RSUs vest over three years in substantially equal quarterly installments based on continued service.
This stock option vests over four years in equal monthly installments based on continued service.
Mark A. Wilson, Attorney-in-Fact
2020-12-22